Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

Por um escritor misterioso

Descrição

Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Antibody–drug conjugates: in search of partners of choice: Trends in Cancer
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors - ScienceDirect
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Antibodies, Free Full-Text
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Cells, Free Full-Text
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Molecules, Free Full-Text
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach - ScienceDirect
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Antibody–drug conjugates: Recent advances in payloads - ScienceDirect
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Frontiers A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody–Drug Conjugate Targeting c-Met Overexpression Tumors
Understanding the activity of antibody–drug conjugates in primary and  secondary brain tumours
Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody–Drug Conjugates
de por adulto (o preço varia de acordo com o tamanho do grupo)